Silexion Therapeutics (SLXN) Interest Income - Total (2024 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Interest Income - Total of $32000.0 for Q1 2026, up 1500.0% year-over-year from $2000.0 in Q1 2025, and down 53.62% quarter-over-quarter from $69000.0 in Q4 2025.
Silexion Therapeutics (SLXN) Interest Income - Total (2024 - 2026) Analysis & Trends
Silexion Therapeutics' Interest Income - Total history runs 3 years deep, the most recent figure standing at $32000.0 for Q1 2026.
- In Q1 2026, Interest Income - Total rose 1500.0% year-over-year to $32000.0; the TTM figure through Mar 2026 stood at $184000.0 (up 1572.73% YoY), while the FY2025 annual figure was $155000.0, up 453.57% from the prior year.
- Interest Income - Total for Q1 2026 stood at $32000.0, down from $69000.0 in the prior quarter.
- The five-year high for Interest Income - Total was $69000.0 in Q4 2025, with the low at $2000.0 in Q1 2025.
- The 3-year median for Interest Income - Total is $25500.0 (2024), against an average of $26750.0.
- Peak annual rise in Interest Income - Total reached 2200.0% in 2025, while the deepest fall reached 89.47% in 2025.
- Silexion Therapeutics' Interest Income - Total stood at $3000.0 in 2024, then jumped by 2200.0% to $69000.0 in 2025, then sank by 53.62% to $32000.0 in 2026.
- Business Quant data shows SLXN's Interest Income - Total at $32000.0 in Q1 2026, $69000.0 in Q4 2025, and $39000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | 14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14,000.00 |
| Jun 30, 2026 | 14,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |